Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer

Katoh, H., & Watanabe, M. (2015). Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer. Mediators of Inflammation, 2015(), 415-426-037. https://doi.org/10.1155/2015/159269
Sanzo, M., Colucci, R., Arunachalam, M., Berti, S., & Moretti, S. (2010). Stress as a Possible Mechanism in Melanoma Progression. Dermatology Research and Practice, 2010(), 211-214. https://doi.org/10.1155/2010/483493
Nicot, C. (2015). Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia. Journal of Oncology, 2015(), 213-223. https://doi.org/10.1155/2015/183590
Vereecken, P., Cornelis, F., Baren, N. V., Vandersleyen, V., & Baurain, J. F. (2012). A Synopsis of Serum Biomarkers in Cutaneous Melanoma Patients. Dermatology Research and Practice, 2012(), 80-86. https://doi.org/10.1155/2012/260643
Baumgartner, J. M., Palmer, B. E., Banerjee, A., & McCarter, M. D. (2008). Role of Melanoma Secreted Thrombospondin-1 on Induction of Immunosuppressive Regulatory T Cells through CD47. Journal of Cancer Molecules, 4(5), 145-152. https://doi.org/10.29685/JCM.200812.0003